MeSH tree: C06.552.241.519
Non-alcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-associated fatty liver disease (MAFLD), is spectrum of diseases that ranges from non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis ...
Jan 22, 2024
0
49
According to a study conducted on animal models and published in the journal Metabolism, aerobic exercise could help fight non-alcoholic fatty liver disease, the most common liver disease worldwide: it affects nearly 24% ...
Jan 22, 2024
0
35
Recent research, which involved 2543 participants across four Chinese cities, employed spirometry and liver ultrasonography to assess lung function and liver health, respectively. The findings indicated that individuals with ...
Dec 16, 2023
0
49
Non-alcoholic fatty liver disease (NAFLD), characterized by excessive hepatic lipid accumulation, poses a high prevalence and can progress to cirrhosis and liver cancer. To enhance preventive and therapeutic efforts, an in-depth ...
Dec 11, 2023
0
37
The global rise in obesity and diabetes is leading to an epidemic in fatty liver disease affecting 20%–30% of the world's population. Almost a third of people with fatty liver disease go on to develop an advanced form of ...
Dec 7, 2023
0
47
The burden of nonalcoholic fatty liver disease (NAFLD) is predicted to continue increasing, according to a study presented at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases, ...
Nov 21, 2023
0
31
In the United States, liver cancer rates have more than tripled since 1980. Some groups, including Latinos, face an even higher risk than the general population—but researchers do not fully understand why.
Nov 20, 2023
0
29
Retatrutide, an experimental weight-loss drug that could compete against blockbusters Wegovy and Zepbound, may work wonders for obese folks with liver disease, new research shows.
Nov 15, 2023
0
50
New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, shows that treating rheumatoid arthritis with hydroxychloroquine (HCQ) reduced the risk of nonalcoholic fatty liver disease, ...
Nov 7, 2023
0
64
Teens from low-income families experiencing food insecurity are developing the most common form of liver disease twice as often as those who have easier access to food, likely because they rely on low-cost, ultra-processed ...
Nov 7, 2023
0
63
